These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 8971280)
61. Incidence of liver toxicity in inflammatory bowel disease patients treated with methotrexate: a meta-analysis of clinical trials. Khan N; Abbas AM; Whang N; Balart LA; Bazzano LA; Kelly TN Inflamm Bowel Dis; 2012 Feb; 18(2):359-67. PubMed ID: 21751301 [TBL] [Abstract][Full Text] [Related]
62. Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Aponte J; Petrelli M Arthritis Rheum; 1988 Dec; 31(12):1457-64. PubMed ID: 3196364 [TBL] [Abstract][Full Text] [Related]
63. Toxicity of low dose methotrexate in rheumatoid arthritis. Weinblatt ME J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():35-9. PubMed ID: 3913775 [TBL] [Abstract][Full Text] [Related]
64. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. Lertnawapan R; Chonprasertsuk S; Siramolpiwat S Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876 [TBL] [Abstract][Full Text] [Related]
65. Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials. Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ Semin Arthritis Rheum; 2015 Oct; 45(2):156-62. PubMed ID: 26088004 [TBL] [Abstract][Full Text] [Related]
66. The practical use of methotrexate in psoriasis. Tung JP; Maibach HI Drugs; 1990 Nov; 40(5):697-712. PubMed ID: 2292232 [TBL] [Abstract][Full Text] [Related]
67. Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients. Erickson AR; Reddy V; Vogelgesang SA; West SG Arthritis Rheum; 1995 Aug; 38(8):1115-9. PubMed ID: 7639808 [TBL] [Abstract][Full Text] [Related]
68. Hepatotoxicity caused by methotrexate therapy in children with inflammatory bowel disease: a systematic review and meta-analysis. Valentino PL; Church PC; Shah PS; Beyene J; Griffiths AM; Feldman BM; Kamath BM Inflamm Bowel Dis; 2014 Jan; 20(1):47-59. PubMed ID: 24280876 [TBL] [Abstract][Full Text] [Related]
69. Hepatic ultrastructure after methotrexate therapy for rheumatoid arthritis. Bjorkman DJ; Hammond EH; Lee RG; Clegg DO; Tolman KG Arthritis Rheum; 1988 Dec; 31(12):1465-72. PubMed ID: 3196365 [TBL] [Abstract][Full Text] [Related]
70. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines? Yazici Y; Erkan D; Paget SA J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713 [No Abstract] [Full Text] [Related]
75. Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Patient Guide. American Gastroenterological Association Gastroenterology; 2017 Sep; 153(3):860-861. PubMed ID: 28774545 [No Abstract] [Full Text] [Related]
76. Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going? Kremer JM J Rheumatol; 1992 Feb; 19(2):189-91. PubMed ID: 1629814 [No Abstract] [Full Text] [Related]
77. [Methotrexate treatment in non-cancerous disorders]. Cogan E Rev Med Brux; 1995; 16(4):300-3. PubMed ID: 7481247 [TBL] [Abstract][Full Text] [Related]
78. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate]. Dietz O; Pachaly A; Schillat I Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519 [No Abstract] [Full Text] [Related]
79. Methotrexate: adverse reactions and major toxicities. Goodman TA; Polisson RP Rheum Dis Clin North Am; 1994 May; 20(2):513-28. PubMed ID: 8016424 [TBL] [Abstract][Full Text] [Related]